AU Patent

AU2015201750A1 — Improved methods and compositions for safe and effective treatment of erythema

Assigned to Galderma Research and Development SNC · Expires 2015-04-30 · 11y expired

What this patent protects

Improved methods and compositions for safe and effective treatment of erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical composition comprising about 0.3% to about 10% by weight of b…

USPTO Abstract

Improved methods and compositions for safe and effective treatment of erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical composition comprising about 0.3% to about 10% by weight of brimonidine and a pharmaceutically acceptable carrier. 6361193_1 (GHMaers) P91331.AU.1 ONIAM Figure I. DaY 15 Dav 29 $3040 0- 3 6 9 Q 3 6 12 3 ie1 Time Poini (hour) -- 2-- 09iQD - 0 I nBID ----- 0.18%QD k elde- - l

Drugs covered by this patent

Patent Metadata

Patent number
AU2015201750A1
Jurisdiction
AU
Classification
—
Expires
2015-04-30
Drug substance claim
No
Drug product claim
No
Assignee
Galderma Research and Development SNC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.